• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    More On TTH.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Transition Therapeutics Inc. (TTH.TO)

    -Toronto
    8.08 0.00(0.00%) Dec 23, 1:51PM EST
    Add to Portfolio
    Prev Close:8.08
    Open:7.85
    Bid:7.16
    Ask:8.08
    1y Target Est:N/A
    Beta:0.66
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:7.85 - 8.08
    52wk Range:4.80 - 9.25
    Volume:322
    Avg Vol (3m):1,751
    Market Cap:284.63M
    P/E (ttm):N/A
    EPS (ttm):-1.10
    Div & Yield:0.06 (0.20%)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for TTH.TO

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:29-Dec-10

    Analysts

    Annual EPS Est (Jun-15) :-1.05
    Quarterly EPS Est (Dec-14) :-0.28
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback